Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) Short Interest Update

Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) saw a large growth in short interest during the month of September. As of September 15th, there was short interest totalling 3,083,800 shares, a growth of 11.8% from the August 31st total of 2,757,700 shares. Based on an average daily volume of 2,300 shares, the short-interest ratio is currently 1,340.8 days.

Genomma Lab Internacional Price Performance

Shares of Genomma Lab Internacional stock remained flat at $1.13 during trading on Friday. The company’s 50-day simple moving average is $1.01 and its two-hundred day simple moving average is $0.96. Genomma Lab Internacional has a 12-month low of $0.79 and a 12-month high of $1.13.

Genomma Lab Internacional Company Profile

Genomma Lab Internacional, SAB. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Latin America. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and sexual improvement, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, and infant nutrition.